PITTSBURGH, Dec. 18, 2025 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced four recent regulatory milestones spanning across all stages of its global pipeline: ...
US pharma Viatris (Nasdaq: VTRS) has logged four regulatory milestones across its global pipeline, spanning a US Food and ...
A new study found that a sizable minority of people with migraine with aura still receive prescriptions for estrogen-containing birth control pills ...
The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...
Melissa Fleur Afshar is a Newsweek reporter based in London, United Kingdom. Her current focus is on trending life stories ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback